Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIMATOPROST vs BIMEKIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIMATOPROST vs BIMEKIZUMAB: Safety Overview

Metric BIMATOPROST BIMEKIZUMAB
Total FAERS Reports 14,752 2,459
Deaths Reported 74 31
Death Rate 0.5% 1.3%
Hospitalizations 245 565
Average Patient Age 62.3 yrs 52.9 yrs
% Female Patients 77.6% 59.9%
FDA Approval Date Apr 12, 2019 N/A
Manufacturer Gland Pharma Limited UCB, Inc.
Route OPHTHALMIC SUBCUTANEOUS
Marketing Status Discontinued N/A